A recently discovered series of inhibitors of the ATPase function of bacterial type IIA topoisomerases featuring a carboxypyrrole component led us to attempt to replace this group with a potentially bioisosteric carboxypyrazole. Accordingly, synthetic pathways to 2-(4-(1Hpyrazole-5-carboxamido)piperidin-1-yl)thiazole-5-carboxylic acids or 2-(4-(N-methyl-1Hpyrazole-5-carboxamido)piperidin-1-yl)thiazole-5-carboxylic acids featuring an array of substituents on the pyrazole ring were explored. Unfortunately, none of the analogues made were effective on the ATPase function of Mycobacterium tuberculosis gyrase, as well on the DNA supercoiling activity of the whole gyrase of M. tuberculosis and Escherichia coli.
have undergone many changes. A remarkable report from a major actor in the domain, reviewing the results of a full genomic approach, led amongst other conclusions to the following statement: "The only way to overcome the challenges of multifactorial antibacterial lead optimization is to expand the number of chemical derivatives. We now employ roughly two chemists for each biologist in the antibacterial therapeutic area, a fourfold turn-around from the days when genomics dominated our activities". 2 The consequence of this has indeed led to extensive medicinal chemistry in the recent past, which notably led to the discovery of many original series of antibiotics inhibiting bacterial type IIA topoisomerases. 3 Amongst these, series of pyrrole-containing inhibitors of the ATPase function of bacterial type IIA topoisomerases such as the compounds 1a-c depicted in figure 1 were reported. 4, 5 Extensive structure-activity studies led to many analogues including the pyrrolo[2,3-c]pyridine derivative 2 6 or the more elaborated triazole-bearing analogue 3. 7 The latter two were actually studied for their antimycobacterial effect on a mice model of M. tuberculosis infection. 8 Replacing the carboxypyrrole by a carboxyimidazole group turned out to be possible and imidazole derivatives such as 4 were also claimed for their inhibition of DNA gyrase and topoisomerase IV as well as their antibacterial effect. 9, 10 Aside from extensive rescaffolding of the central 4-aminopiperidine with other cyclic amines, [11] [12] [13] [14] [15] [16] the 2-(piperidin-1-yl)thiazole component could be replaced, with relative success, by a carboxamide 17 or other heterocycles 18 such as the randomly chosen 4-phenyltriazole 5 19 and more recently, antibacterials such as the tetrahydrobenzo [1,2-d] thiazole 6 were reported. 20 Extensive work D r a f t 5 on the carboxylic acid-bearing component of these series led to compound 7 which featured an improved antibacterial activity as well as a lower in vivo clearances and was thus selected for clinical trials. 21 In view of this, along with our simple method for the preparation of carboxypyrazoles, 22 we set to prepare the pyrazole-bearing series of compounds 8 and 9 in order to determine in this case whether a pyrazole nucleus could also be a bioisostere of the carboxy-pyrrole component. 
Results and discussion
D r a f t 6 As depicted in scheme 1, the pyrazole acids 11a-d were obtained by hydrolysis of the corresponding trifluoromethyl pyrazoles 10a-d, as previously reported 22 or described in the experimental part. Initially, their coupling with the dihydrochloride salt of amine 12, previously described, 23 to give amides 13a-d was achieved using a mixture of phosphorus oxychloride and pyridine. This unusual method has been successfully applied in the past for difficult cases 24 including one involving a pyrazole carboxylic acid. 25 However, if the modest yield obtained could be raised with an excess of the acid and phosphorus oxychloride in some cases we realized later on in the course of the preparation of the N-methyl derivatives 9 that O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TBTU) was a far better coupling agent. To prepare the trifluoromethyl bearing amide 13e, we used the Nprotected acid 14 (preparation described in the experimental part). Coupling of this acid with amine 12 using phosphorus oxychloride and pyridine followed by the cleavage of the ethoxyethyl protecting group gave compound 13e in an 18 % overall yield. Hydrolysis of esters 13a-e to give the target acids 8a-e was achieved using lithium hydroxide as described for the pyrrole series of inhibitors. 23 A relatively large scale (200 mg) and a minimal amount of water were found necessary to isolate, by precipitation, substantial amount of the rather water-soluble acids 8a and 8b. Unfortunately, a complete lack of inhibition effect was observed for the analogues 8a-e on disk-based assays for bacterial strains such as E. coli (data not shown). Moreover, to remove the possibility of a lack of membrane solubility which would have explained these results, compounds 8a-e were also assessed on various bacterial 
For the synthesis of the N-methylated analogues 9a-j, a different synthetic approach to the key intermediate 19 was initially explored. By heating equimolar amount of the Nmethylpyridin-4-amine (15) and the methyl 2-bromothiazole-5-carboxylate (16) in a microwave oven at 100 °C for 15 minutes, a close to quantitative yield of the pyridinium salt 17 was obtained. Treatment of this salt with sodium borohydride in methanol led to a mixture of the partially hydrogenated dihydropyridine 18 and a smaller proportion of the target piperidine 19, which could not be separated at this stage. Reduction trials with various borohydrides did not improve this ratio nor atmospheric palladium-catalyzed hydrogenation of the mixture of 18 and 19. In any case, the coupling of these crude amines with pyrazole carboxylic acids 11a-c, using the much more efficient TBTU, gave a mixture of the amides 20a-c and 21a-c from which the pure 3,4-dihydropyridines 20a-c could be isolated in [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] D r a f t 8 % yield. The LC/MS monitoring of this reaction actually pointed out the occurrence of various pairs of TBTU adducts (i.e.: m/z = 446 and 448 or m/z = 419 and 421, when coupling the mixture of 18 and 19 with acid 11a). This led us to add ammonia in the reaction mixture to decompose them before the reaction work up. The reduction of the dihydropyridine ring of amides 20a-c turned out to be challenging and the only reagents which provided modest amount of the reduced compounds 21a-c (22-45 % yield) was the combination of triethylsilane and trifluoromethane sulfonic acid. Extensive investigation of the various products arising from this ionic-based reduction was made and in the case of compound 20b, we could isolated the tricyclic derivative 22. As described below, the bridged structure of this compound was fully established by an X-ray crystallography study. The mechanism for the occurrence of this compound is quite straightforward, upon protonation of the 3,4dihydropyridine double bond of compound 20b, the resulting cation can either be quenched by the triethylsilane, to give the reduced amide 21b, or react internally with the nucleophilic nitrogen of the pyrazole ring to give 22. Hydrolysis of the methyl ester of compounds 21a-c, to give the target analogues 9a-c, was then achieved as above using lithium hydroxide.
Concerning the 1 H NMR characterization of all these N-methylamides, their 1 H NMR spectra at room temperature pointed out the occurrence of equilibrium between at least two conformations. In every cases, as described in the experimental part, when raising the temperature to 90 °C, all the 1 H NMR signals resolved into a single conformation much easier to describe. For the same reason, the 13 C NMR spectra obtained at room temperature were intractable and no attempts were made to obtain them at 90 °C. Å, θ = 176.9(2)°, ϕ = 120(5)°) suggest that the piperidine ring is in a chair conformation. The dihedral angle between the two planes is 75.7°. 
Conclusion
This work was an attempt to determine whether a carboxypyrazole could, in the present case, be a bioisosteric replacement of a carboxypyrrole. On the chemistry point of view, by using the previously disclosed synthesis of compound 12, 23 Despite this, we hope that this report, which provides some insights in the chemistry of these series as well as in their structure-activity relationships, will still be useful to other investigators.
Experimental part
Disk-based assays. The strain used in this study was E. coli CIP 76.24 (susceptible to ofloxacin). For routine use, this strain was grown at 37 °C on trypticase soy agar plates (BioMérieux, La Balme-Les-Grottes, France). The antimicrobial susceptibility test was performed on Mueller-Hinton agar (BioMérieux, La Balme-Les-Grottes, France) by an agar diffusion method, according to the guidelines of the Antibiogram Committee of the French Society for Microbiology. 31 Each compound was solubilized in DMSO to obtain a solution of 50 mg/ml. The in vitro susceptibility to 5 compounds was tested by the agar dilution method.
These solubilized compounds were used immediately after dilution. The serial dilutions were performed in physiological serum and 10 µL of the dilution were deposited on a blank disk (Biorad). A disk without any compound, and another with 10 µl DMSO were added on the D r a f t 13 plates, as negative controls. All plates were incubated at 37°C for 24h. The strain was fully impervious to the compounds 5a-e tested.
DNA supercoiling assay. The M. tuberculosis DNA gyrase was purified as described previously. 32 The reaction mixture (total volume, 30 µl) contained DNA gyrase assay buffer X-ray analysis. X-ray data were collected at 293 K using CuKα (1.54187 Å) on a Rigaku mm007 HF rotating anode diffractometer equipped with Osmic CMF mirror and a curved imaging-plate RapidII detector. The Rigaku CrystalClear-SM Expert 2.0 r15 software package 34 was used for data collection and data reduction. The data were corrected semiempirically for absorption using multi-scan approach through the Fs Process scaling algorithm. The structure was solved by direct methods using SHELXS-97 35 and refined by full-matrix least squares on F 2 using SHELXL-2014/7. 36 All non-hydrogen atoms were successfully refined using anisotropic displacement parameters. Hydrogen atoms were found in the Fourier difference synthesis and fixed. Crystallographic data for the structure of compound 22 were deposited in the Cambridge Crystallographic Data Centre, with number CCDC 1049028. Chemistry. A Biotage initiator 2 microwave oven was used for reactions mentioning such heating method. 1 H NMR and 13 C NMR spectra were recorded on a Bruker Avance 400 spectrometer at 400 MHz and 100 MHz, respectively. Shifts (δ) are given in ppm with respect to the TMS signal and cross-coupling constants (J) are given in hertz. Column chromatography were performed either on Merck silica gel 60 (0.035 -0.070 mm) or neutral alumina using a solvent pump and an automated collecting system driven by a UV detector set to 254 nm unless required otherwise. Sample deposition was carried out by adsorption of the mixture to be purified on a small amount of the solid phase followed by its deposition on the top of the column. The low resolution mass spectra were obtained on an Agilent 1100 series LC/MSD system using an atmospheric electrospray ionization system and the high resolution mass spectra (HRMS) were obtained using a Waters Micromass Q-Tof with an electrospray ion source. Unless stated otherwise, a purity of at least 95 % was obtained for all the compounds by means of chromatography, recrystallization or distillation and this level of purity was established by TLC, LC/MS and NMR spectroscopy. Moxifloxacin, used as active compound for the supercoiling assays, was provided by Bayer Pharma, Puteaux, France.
D r a f t
General procedure for the hydrolysis of trifluoromethylpyrazole into pyrazole-5carboxylic acid
As previously described for other cases, 22 in a Biotage tube, the relevant trifluoromethylpyrazole (1 mmol) and sodium hydroxide (0.2 g, 5 mmol) were stirred in ethanol/water 1:3 (1.2 mL). The tube was sealed and heated at 150 °C for 1 h in a microwave oven. The resulting suspension was dissolved in water; the aqueous phase was washed with dichloromethane twice and made acidic with 2N hydrochloric acid. This was extracted with ethyl acetate twice; the organic layer were combined and washed with brine, dried over magnesium sulfate, and concentrated to dryness to yield the corresponding acid as described below. CAUTION: the reaction leads to the release of fluorine ions which attack the glass tubes. Never recycle the reaction tubes as their resistance toward pressure and temperature may have been weakened in the process. 37 and N-chlorosuccinimide (1.26 g, 9.46 mmol) were stirred overnight at room temperature and then heated to reflux for 90 minutes.
This was concentrated to dryness, the residue was dispersed in cyclohexane and filtrated. The filtrate was washed with water, dried over magnesium sulfate and concentrated to dryness to yield the 4-chloropyrazole which NMR spectra feature two detectable tautomers. 1 g, 10.69 mmol) in water/tertbutanol 5-1 (60 mL) was stirred at 75 °C for three days. The suspension was filtered, the filtrate made acid using 37 % hydrochloric acid, the resulting precipitate was filtered and dissolved in a 1N sodium hydroxide solution. This aqueous layer was washed with dichloromethane twice, and made acid again using 37 % hydrochloric acid.
This was extracted with ethyl acetate, the organic layer was washed with brine, dried over magnesium sulfate and concentrated to dryness to yield compound 11j as a white powder (0.64 g, 57 %). 1 D r a f t 26 10.02 (s, 1H). 13 
